Cargando…

Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics

Detalles Bibliográficos
Autor principal:	Bandres‐Ciga, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348590/ https://www.ncbi.nlm.nih.gov/pubmed/35488798 http://dx.doi.org/10.1002/mds.29042

Ejemplares similares

The Parkinson's Disease DNA Variant Browser
por: Kim, Jonggeol J., et al.
Publicado: (2021)

Mapping the Diverse and Inclusive Future of Parkinson’s Disease Genetics and Its Widespread Impact
por: Elsayed, Inas, et al.
Publicado: (2021)

The Parkinson's Disease Genome‐Wide Association Study Locus Browser
por: Grenn, Francis P., et al.
Publicado: (2020)

The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
por: Diez-Fairen, Monica, et al.
Publicado: (2021)

Immunogenetic Determinants of Parkinson’s Disease Etiology
por: Kung, Pin-Jui, et al.
Publicado: (2022)

Genetic Risk Profiling in Parkinson’s Disease and Utilizing Genetics to Gain Insight into Disease-Related Biological Pathways
por: Hall, Ashley, et al.
Publicado: (2020)

PTPA variants and the risk for Parkinson’s disease in diverse ancestry populations
por: Ostrožovičová, Miriam, et al.
Publicado: (2023)

Advancing Personalized Medicine in Common Forms of Parkinson’s Disease through Genetics: Current Therapeutics and the Future of Individualized Management
por: Reed, Xylena, et al.
Publicado: (2021)

Bidirectional relationship between olfaction and Parkinson’s disease
por: Kim, Jonggeol J., et al.
Publicado: (2023)

Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
por: Iwaki, Hirotaka, et al.
Publicado: (2021)

MIDN locus structural variants and Parkinson's Disease risk
por: Billingsley, Kimberley J., et al.
Publicado: (2020)

Analysis of rare Parkinson’s disease variants in millions of people
por: Pitz, Vanessa, et al.
Publicado: (2023)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The Myelin‐Weighted Connectome in Parkinson's Disease
por: Boshkovski, Tommy, et al.
Publicado: (2021)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort
por: Brolin, Kajsa, et al.
Publicado: (2022)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
por: Pagan, Fernando L., et al.
Publicado: (2020)

GP2: The Global Parkinson's Genetics Program
Publicado: (2021)

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson’s Disease
por: Jensen, Melanie P., et al.
Publicado: (2021)

Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
por: Alvarez Jerez, Pilar, et al.
Publicado: (2023)

RIC3 variants are not associated with Parkinson’s disease in large European, Latin American, or East Asian cohorts
por: Brolin, Kajsa, et al.
Publicado: (2022)

Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
por: Dommershuijsen, Lisanne J., et al.
Publicado: (2020)

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review
por: Carey, Guillaume, et al.
Publicado: (2020)

A Multi‐Step Model of Parkinson's Disease Pathogenesis
por: Le Heron, Campbell, et al.
Publicado: (2021)

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
por: Omer, Nurit, et al.
Publicado: (2021)

Functional connectivity markers of depression in advanced Parkinson's disease
por: Lin, Hai, et al.
Publicado: (2019)

Heritability Enrichment Implicates Microglia in Parkinson’s Disease Pathogenesis
por: Andersen, Maren Stolp, et al.
Publicado: (2021)

Unraveling the genetic complexity of Alzheimer disease with Mendelian Randomization
por: Bandres-Ciga, Sara, et al.
Publicado: (2019)

Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research
por: Rajan, Roopa, et al.
Publicado: (2020)

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study
por: Kang, Xiaoying, et al.
Publicado: (2021)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

Cerebello‐Cortical Control of Tremor Rhythm and Amplitude in Parkinson's Disease
por: Helmich, Rick C., et al.
Publicado: (2021)

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2020)

Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity
por: Werner, Milton H., et al.
Publicado: (2021)

MIND and Mediterranean Diets Associated with Later Onset of Parkinson's Disease
por: Metcalfe‐Roach, Avril, et al.
Publicado: (2021)

Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease
por: Galper, Jasmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fi8aggs2lh7mv86lq6p27c0hk7